- Page 1 and 2: (Mark One) UNITED STATES SECURITIES
- Page 3 and 4: XTL BIOPHARMACEUTICALS LTD. ANNUAL
- Page 5 and 6: PART I Unless the context requires
- Page 7 and 8: Risk Factors Before you invest in o
- Page 9 and 10: • manufacture our drug candidates
- Page 11 and 12: • our inability to maintain relat
- Page 13 and 14: We also rely on trade secrets to pr
- Page 15 and 16: • conditions or trends in the reg
- Page 17 and 18: Our ADR holders do not have the sam
- Page 19 and 20: ITEM 4. INFORMATION ON THE COMPANY
- Page 21 and 22: Products Under Development Bicifadi
- Page 23 and 24: Given the limited efficacy of the p
- Page 25 and 26: Licensing Agreements and Collaborat
- Page 27 and 28: The regulatory review and approval
- Page 29: We anticipate that these facilities
- Page 33 and 34: We expect our overall research and
- Page 35 and 36: We account for equity instruments i
- Page 37 and 38: SFAS No. 157, “Fair Value Measure
- Page 39 and 40: We have based our estimate on assum
- Page 41 and 42: Years ended December 31, 2007 2006
- Page 43 and 44: Ben Zion Weiner has served as a dir
- Page 45 and 46: During 2007, we granted a total of
- Page 47 and 48: Our audit committee is currently co
- Page 49 and 50: Share Ownership The following table
- Page 51 and 52: ITEM 7. MAJOR SHAREHOLDERS AND RELA
- Page 53 and 54: ITEM 10. ADDITIONAL INFORMATION Mem
- Page 55 and 56: In addition, any controlling shareh
- Page 57 and 58: Rights of Shareholders Under the Is
- Page 59 and 60: We urge shareholders to consult the
- Page 61 and 62: In any case, dividends distributed
- Page 63 and 64: A US holder that uses the cash meth
- Page 65 and 66: • the Non-US holder is subject to
- Page 67 and 68: PART II ITEM 13. DEFAULTS, DIVIDEND
- Page 69 and 70: ITEM 17. FINANCIAL STATEMENTS PART
- Page 71 and 72: 23.1 Consent of Kesselman & Kesselm
- Page 73 and 74: XTL BIOPHARMACEUTICALS LTD. (A Deve
- Page 75 and 76: The Company’s Board of Directors
- Page 77 and 78: Date of approval of the financial s
- Page 79 and 80: ** Represents an amount less than $
- Page 81 and 82:
** Represents an amount less than $
- Page 83 and 84:
XTL BIOPHARMACEUTICALS LTD. (A Deve
- Page 85 and 86:
NOTE 1 - SIGNIFICANT ACCOUNTING POL
- Page 87 and 88:
NOTE 1 - SIGNIFICANT ACCOUNTING POL
- Page 89 and 90:
NOTE 1 - SIGNIFICANT ACCOUNTING POL
- Page 91 and 92:
NOTE 1 - SIGNIFICANT ACCOUNTING POL
- Page 93 and 94:
NOTE 2 - BICIFADINE TRANSACTION (co
- Page 95 and 96:
NOTE 4 - LICENSE AGREEMENT WITH CUB
- Page 97 and 98:
NOTE 6 - EMPLOYEE SEVERANCE OBLIGAT
- Page 99 and 100:
NOTE 7 - SHAREHOLDERS’ EQUITY (co
- Page 101 and 102:
NOTE 7 - SHAREHOLDERS’ EQUITY (co
- Page 103 and 104:
NOTE 7 - SHAREHOLDERS’ EQUITY (co
- Page 105 and 106:
NOTE 7 - SHAREHOLDERS’ EQUITY (co
- Page 107 and 108:
NOTE 8 - COMMITMENTS AND CONTINGENC
- Page 109 and 110:
NOTE 9 - INCOME TAXES (continued) 2
- Page 111 and 112:
NOTE 10 - RESTRUCTURING XTL BIOPHAR
- Page 113 and 114:
NOTE 13 - SUBSEQUENT EVENTS XTL BIO
- Page 115 and 116:
“Effective Date” means the date
- Page 117 and 118:
2.2 Closing Conditions. (a) As a co
- Page 119 and 120:
(iv) the Escrow Agreement duly exec
- Page 121 and 122:
(c) No Conflicts. The execution, de
- Page 123 and 124:
(h) Litigation. Except as would not
- Page 125 and 126:
(r) Offering Materials. The Company
- Page 127 and 128:
(b) General Solicitation. Such Purc
- Page 129 and 130:
4.2 Furnishing of Information. Duri
- Page 131 and 132:
5.2 Entire Agreement. The Transacti
- Page 133 and 134:
5.14 Independent Nature of Purchase
- Page 135 and 136:
Date: March 19, 2006 BANK JULIUS BA
- Page 137 and 138:
Date: March 17 2006 CATALYTIX, LDC
- Page 139 and 140:
Date: March 19, 2006 APEX INVESTMEN
- Page 141 and 142:
AVIZ RAIZ Date: March 18, 2006 [PUR
- Page 143 and 144:
CIMARRON BIOMEDICAL EQUITY MASTER F
- Page 145 and 146:
FORMULA INVESTMENT HOUSE LTD. Date:
- Page 147 and 148:
FORE ERISA FUND, LTD. Date: March 1
- Page 149 and 150:
GLG NORTH AMERICAN OPPORTUNITY FUND
- Page 151 and 152:
Date: March 17, 2006 IROQUOIS MASTE
- Page 153 and 154:
Date: March 17, 2006 KENNETH HOBERM
- Page 155 and 156:
Date: March 17, 2006 MAN MAC I, LTD
- Page 157 and 158:
MERLIN BIOMED II, LP Date: March 17
- Page 159 and 160:
MERLIN BIOMED INTERNATIONAL, LTD. D
- Page 161 and 162:
NARRAGANSETT I, LP Date: March 17,
- Page 163 and 164:
NORTH SOUND LEGACY INSTITUTIONAL FU
- Page 165 and 166:
PORTSIDE GROWTH AND OPPORTUNITY FUN
- Page 167 and 168:
RAQ, LLC Date: March 17, 2006 [PURC
- Page 169 and 170:
Date: March 17, 2006 SENVEST MASTER
- Page 171 and 172:
SONOSTAR CAPITAL PARTNERS LLC Date:
- Page 173 and 174:
VALESCO HEALTHCARE PARTNERS II LP D
- Page 175 and 176:
YOURDENT LTD Date: March 18, 2006 [
- Page 177 and 178:
3. Please describe the relationship
- Page 179 and 180:
2. The Subsidiary is a corporation,
- Page 181 and 182:
REGISTRATION RIGHTS AGREEMENT Exhib
- Page 183 and 184:
(b) If: (i) the Registration Statem
- Page 185 and 186:
(c) (i) Prepare and file with the C
- Page 187 and 188:
(i) Comply with all applicable rule
- Page 189 and 190:
(b) Indemnification by Holders. Eac
- Page 191 and 192:
The parties hereto agree that it wo
- Page 193 and 194:
(i) Counterparts. This Agreement ma
- Page 195 and 196:
IN WITNESS WHEREOF, the parties hav
- Page 197 and 198:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 199 and 200:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 201 and 202:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 203 and 204:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 205 and 206:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 207 and 208:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 209 and 210:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 211 and 212:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 213 and 214:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 215 and 216:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 217 and 218:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 219 and 220:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 221 and 222:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 223 and 224:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 225 and 226:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 227 and 228:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 229 and 230:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 231 and 232:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 233 and 234:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 235 and 236:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 237 and 238:
Exhibit A Plan of Distribution The
- Page 239 and 240:
SECURITIES PURCHASE AGREEMENT Exhib
- Page 241 and 242:
“Registration Statement” means
- Page 243 and 244:
With respect to the closing conditi
- Page 245 and 246:
(a) Organization and Qualification.
- Page 247 and 248:
(g) No Material Change. Since June
- Page 249 and 250:
(m) Governmental Permits, Etc. The
- Page 251 and 252:
(y) Independent Public Accountants.
- Page 253 and 254:
(h) No Governmental Review. Such Pu
- Page 255 and 256:
4.8 Subsequent Financings Prior to
- Page 257 and 258:
5.10 Survival. The representations,
- Page 259 and 260:
Date: October 25, 2007 EYAL CARMON
- Page 261 and 262:
MANIV (BRUNSTEIN) BUSINESS PROMOTIO
- Page 263 and 264:
Date: October 25, 2007 PUNK ZIEGEL
- Page 265 and 266:
Date: October 25, 2007 MEITAV PENSI
- Page 267 and 268:
Date: October 25, 2007 MEITAV GEMEL
- Page 269 and 270:
SONOSTAR CAPITAL PARTNERS, LLC Date
- Page 271 and 272:
Date: October 25, 2007 DAVID TUBOUL
- Page 273 and 274:
PERCEPTIVE LIFE SCIENCES MASTER FUN
- Page 275 and 276:
Date: October 22, 2007 TMW CAPITAL,
- Page 277 and 278:
Date: October 22, 2007 CAT TRAIL CA
- Page 279 and 280:
Date: October 19, 2007 JAMES F. OLI
- Page 281 and 282:
Date: October 19, 2007 JAMES D. KUH
- Page 283 and 284:
Date: October 19, 2007 PROMED PARTN
- Page 285 and 286:
SENVEST ISRAEL PARTNERS LP Date: Oc
- Page 287 and 288:
CLEARWATER OFFSHORE FUND, LTD. Date
- Page 289 and 290:
Date: October 19, 2007 SENVEST MAST
- Page 291 and 292:
3. Please describe the relationship
- Page 293 and 294:
Form of Opinion of Kantor & Co. Exh
- Page 295 and 296:
Alston & Bird to also confirm: We h
- Page 297 and 298:
• Also, the Company may issue Ord
- Page 299 and 300:
“Proceeding” means an action, c
- Page 301 and 302:
(c) The Holders holding at least a
- Page 303 and 304:
(e) Promptly deliver to each Holder
- Page 305 and 306:
5. Indemnification (a) Indemnificat
- Page 307 and 308:
Subject to the terms of this Agreem
- Page 309 and 310:
(f) Piggy-Back Registrations. If at
- Page 311 and 312:
(o) Independent Nature of Purchaser
- Page 313 and 314:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 315 and 316:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 317 and 318:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 319 and 320:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 321 and 322:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 323 and 324:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 325 and 326:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 327 and 328:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 329 and 330:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 331 and 332:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 333 and 334:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 335 and 336:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 337 and 338:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 339 and 340:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 341 and 342:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 343 and 344:
[SIGNATURE PAGE OF HOLDERS TO RRA]
- Page 345 and 346:
The selling shareholders also may t
- Page 347 and 348:
Confidential material omitted and f
- Page 349 and 350:
Confidential material omitted and f
- Page 351 and 352:
LICENSE AGREEMENT This License Agre
- Page 353 and 354:
Section 1.12 “Development” or
- Page 355 and 356:
Confidential material omitted and f
- Page 357 and 358:
Confidential material omitted and f
- Page 359 and 360:
Confidential material omitted and f
- Page 361 and 362:
Confidential material omitted and f
- Page 363 and 364:
Confidential material omitted and f
- Page 365 and 366:
Confidential material omitted and f
- Page 367 and 368:
Confidential material omitted and f
- Page 369 and 370:
Confidential material omitted and f
- Page 371 and 372:
otherwise recovered; and Confidenti
- Page 373 and 374:
Confidential material omitted and f
- Page 375 and 376:
Confidential material omitted and f
- Page 377 and 378:
Confidential material omitted and f
- Page 379 and 380:
Confidential material omitted and f
- Page 381 and 382:
Confidential material omitted and f
- Page 383 and 384:
Section 11.2 Governing Law . This A
- Page 385 and 386:
Section 11.9 Headings . The caption
- Page 387 and 388:
***** ***** ***** Copies of the for
- Page 389 and 390:
***** Confidential material omitted
- Page 391 and 392:
***** Confidential material omitted
- Page 393 and 394:
***** ***** ***** ***** ***** Confi
- Page 395 and 396:
CONSENT OF INDEPENDENT REGISTERED P
- Page 397 and 398:
I, Ron Bentsur, certify that: CERTI
- Page 399 and 400:
CERTIFICATION PURSUANT TO 18 U.S.C.